Valuation: Alcon

Market Cap 3.33TCr 2.93TCr 2.7TCr 2.53TCr 4.73TCr 3,13500Cr 4.82TCr 32TCr 13TCr 1,54600Cr 12TCr 12TCr 5,38000Cr P/E 2026 *
31.6x
P/E 2027 * 24.6x
Enterprise Value 3.59TCr 3.16TCr 2.91TCr 2.72TCr 5.1TCr 3,38000Cr 5.2TCr 35TCr 14TCr 1,66700Cr 13TCr 13TCr 5,80100Cr EV / Sales 2026 *
3.22x
EV / Sales 2027 * 2.94x
Free-Float
97.36%
Yield 2026 *
0.52%
Yield 2027 * 0.6%
Manager TitleAgeSince
Chief Executive Officer 60 01/07/2018
Director of Finance/CFO 58 08/04/2019
Chief Tech/Sci/R&D Officer - 01/01/2025
Director TitleAgeSince
Director/Board Member 60 -
Chairman 70 01/07/2018
Director/Board Member 63 01/02/2019
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 3.33TCr
+0.27%-3.52%-30.45%+0.62% 8.8TCr
+4.05%+5.81%-2.96%-26.14% 1.34TCr
+0.08%+2.54% - - 951.21Cr
-3.16%-13.29%-9.60%+510.90% 208.06Cr
-2.69%-2.95%-27.79%-63.31% 142.85Cr
-2.27%-6.98%-44.88%-33.25% 83Cr
+0.15%+4.65%+9.21%-6.32% 79Cr
+3.41%+5.39%+54.13%-32.30% 75Cr
+0.26%+2.10%+7.46%-11.19% 39Cr
Average +0.03%-1.25%-5.61%+42.38% 1.3TCr
Weighted average by Cap. +0.48%-2.05%-25.68%+5.71%

Financials

2026 *2027 *
Net sales 1.11TCr 979.59Cr 903.55Cr 845.07Cr 1.58TCr 1,04900Cr 1.61TCr 11TCr 4.21TCr 52TCr 4.18TCr 4.09TCr 1,80000Cr 1.18TCr 1.04TCr 959.81Cr 897.69Cr 1.68TCr 1,11400Cr 1.71TCr 12TCr 4.47TCr 55TCr 4.44TCr 4.34TCr 1,91200Cr
Net income 108.51Cr 96Cr 88Cr 82Cr 154.41Cr 10TCr 157.29Cr 1.06TCr 410.16Cr 5.05TCr 407.39Cr 398.56Cr 18TCr 137.97Cr 121.47Cr 112.04Cr 104.79Cr 196.34Cr 13TCr 200.01Cr 1.35TCr 521.54Cr 6.42TCr 518.02Cr 506.79Cr 22TCr
Net Debt 259.87Cr 228.79Cr 211.03Cr 197.37Cr 369.81Cr 24TCr 376.71Cr 2.54TCr 982.32Cr 12TCr 975.69Cr 954.54Cr 42TCr 154.37Cr 135.91Cr 125.36Cr 117.25Cr 219.68Cr 15TCr 223.78Cr 1.51TCr 583.54Cr 7.18TCr 579.6Cr 567.03Cr 25TCr
Logo Alcon
Alcon Inc. is the global leader in the design, manufacture and marketing of ophthalmic care products. Net sales break down by category of products as follows: - ophthalmic surgical products and equipment (55.7%): consumables (52.7% of net sales), implantable products (31%) and other products (16.3%; in particular surgical equipment) for the treatment of cataracts, retinal diseases, glaucoma and refractive errors; - vision care products (44.3%): contact lenses (60.6% of sales) and eye care products (39.4%; eye drops and ophthalmic ointments, etc.). At the end of 2025, the group operated 17 production sites worldwide. Net sales are distributed geographically as follows: Switzerland (0.7%), the United States (45.1%), Japan (5.9%), China (5.5%), and Other (42.8%).
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
AAA